Magnetoferritin nanoparticles for targeting and visualizing tumour tissues
Source abstract
Abstract
Engineered nanoparticles have been used to provide diagnostic, therapeutic and prognostic information about the status of disease. Nanoparticles developed for these purposes are typically modified with targeting ligands (such as antibodies, peptides or small molecules) or contrast agents using complicated processes and expensive reagents. Moreover, this approach can lead to an excess of ligands on the nanoparticle surface, and this causes non-specific binding and aggregation of nanoparticles, which decreases detection sensitivity. Here, we show that magnetoferritin nanoparticles (M-HFn) can be used to target and visualize tumour tissues without the use of any targeting ligands or contrast agents. Iron oxide nanoparticles are encapsulated inside a recombinant human heavy-chain ferritin (HFn) protein shell, which binds to tumour cells that overexpress transferrin receptor 1 (TfR1). The iron oxide core catalyses the oxidation of peroxidase substrates in the presence of hydrogen peroxide to produce a colour reaction that is used to visualize tumour tissues. We examined 474 clinical specimens from patients with nine types of cancer and verified that these nanoparticles can distinguish cancerous cells from normal cells with a sensitivity of 98% and specificity of 95%.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Advanced biosensing and bioanalysis techniques · Iron Metabolism and Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Galanzha, E. I. et al. In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nature Nanotech. 4, 855–860 (2009).10.1038/nnano.2009.333 ↗
2. Winter, P. M. et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel ανβ3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 63, 5838–5843 (2003).
3. Stoeva, S. I., Lee, J. S., Smith, J. E., Rosen, S. T. & Mirkin, C. A. Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes. J. Am. Chem. Soc. 128, 8378–8379 (2006).10.1021/ja0613106 ↗
4. Janib, S. M., Moses, A. S. & Mackay, J. A. Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Del. Rev. 3, 1–2 (2010).
5. Zrazhevskiy, P., Sena, M. & Gao, X. H. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem. Soc. Rev. 3, 1–2 (2010).
6. Li, R. L. et al. Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology. Clin. Cancer Res. 15, 3568–3573 (2009).10.1158/1078-0432.CCR-08-0826 ↗
7. Karathanasis, E. et al. Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. Biomaterials 29, 4815–4822 (2008).10.1016/j.biomaterials.2008.08.036 ↗
8. Jaetao, J. E. et al. Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles. Cancer Res. 69, 8310–8316 (2009).10.1158/0008-5472.CAN-09-1083 ↗
9. Corsi, F. et al. HER2 expression in breast cancer cells is downregulated upon active targeting by antibody-engineered multifunctional nanoparticles in mice. ACS Nano 5, 6383–6393 (2011).10.1021/nn201570n ↗
10. Xu, H. Y. et al. Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. Biomaterials 32, 9758–9765 (2011).10.1016/j.biomaterials.2011.08.076 ↗
11. Park, Y. et al. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. J. Control. Rel. 128, 217–223 (2008).10.1016/j.jconrel.2008.03.019 ↗
12. Kumar, A. et al. Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials 33, 1180–1189 (2012).10.1016/j.biomaterials.2011.10.058 ↗
13. Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T. & Josephson, L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nature Biotechnol. 23, 1418–1423 (2005).10.1038/nbt1159 ↗
14. Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. & Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nature Biotechnol. 22, 969–976 (2004).10.1038/nbt994 ↗
15. Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–544 (2005).10.1126/science.1104274 ↗
16. Jin, Y. D., Jia, C. X., Huang, S. W., O'Donnell, M. & Gao, X. H. Multifunctional nanoparticles as coupled contrast agents. Nature Commun. 1, 1–8 (2010).10.1038/ncomms1042 ↗
17. Chen, H. W. et al. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PγMPS copolymer coating. Biomaterials 31, 5397–5407 (2010).10.1016/j.biomaterials.2010.03.036 ↗
18. Bagwe, R. P., Hilliard, L. R. & Tan, W. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 22, 4357–4362 (2006).10.1021/la052797j ↗
19. Grubbs, R. B. Roles of polymer ligands in nanoparticle stabilization. Polym. Rev. 47, 197–215 (2007).10.1080/15583720701271245 ↗
20. Doshi, N. & Mitragotri, S. Designer biomaterials for nanomedicine. Adv. Funct. Mater. 19, 3843–3854 (2009).10.1002/adfm.200901538 ↗
21. Theil, E. C. Ferritin-structure, gene-regulation, and cellular function in animals, plants, and microorganisms. Annu. Rev. Biochem. 56, 289–315 (1987).10.1146/annurev.bi.56.070187.001445 ↗
22. Meldrum, F. C., Heywood, B. R. & Mann, S. Magnetoferritin: in vitro synthesis of a novel magnetic protein. Science 257, 522–523 (1992).10.1126/science.1636086 ↗
23. Douglas, T. & Young, M. Host–guest encapsulation of materials by assembled virus protein cages. Nature 393, 152–155 (1998).10.1038/30211 ↗
24. Allen, M., Willits, D., Mosolf, J., Young, M. & Douglas, T. Protein cage constrained synthesis of ferrimagnetic iron oxide nanoparticles. Adv. Mater. 14, 1562–1565 (2002).10.1002/1521-4095(20021104)14:21<1562::AID-ADMA1562>3.0.CO;2-D ↗
25. Li, L. et al. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc. Natl Acad. Sci. USA 107, 3505–3510 (2010).10.1073/pnas.0913192107 ↗
26. Sutherland, R. et al. Ubiquitous cell-surface glycoprotein on tumor-cells is proliferation-associated receptor for transferrin. Proc. Natl Acad. Sci. USA 78, 4515–4519 (1981).10.1073/pnas.78.7.4515 ↗
27. Ryschich, E. et al. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur. J. Cancer 40, 1418–1422 (2004).10.1016/j.ejca.2004.01.036 ↗
28. Walker, R. A. & Day, S. J. Transferrin receptor expression in non-malignant and malignant human breast tissue. J. Pathol. 148, 217–224 (1986).10.1002/path.1711480305 ↗
29. Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G. & Penichet, M. L. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 121, 144–158 (2006).10.1016/j.clim.2006.06.010 ↗
30. Uchida, M. et al. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J. Am. Chem. Soc. 128, 16626–16633 (2006).10.1021/ja0655690 ↗
31. Lin, X. et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett. 11, 814–819 (2011).10.1021/nl104141g ↗
32. Lin, X. et al. Hybrid ferritin nanoparticles as activatable probes for tumor imaging. Angew. Chem. Int. Ed. 50, 1569–1572 (2011).10.1002/anie.201006757 ↗
33. Gao, L. Z. et al. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nature Nanotech. 2, 577–583 (2007).10.1038/nnano.2007.260 ↗
34. Cao, C. Q. et al. Magnetic characterization of noninteracting, randomly oriented, nanometer-scale ferrimagnetic particles. J. Geophys. Res. 115, B07103 (2010).
35. Mann, S., Bannister, J. V. & Williams, R. J. Structure and composition of ferritin cores isolated from human spleen, limpet (Patella vulgata) hemolymph and bacterial (Pseudomonas aeruginosa) cells. J. Mol. Biol. 188, 225–232 (1986).10.1016/0022-2836(86)90307-4 ↗